TOMMIE SIMON M.D. NPI 1043653264

NPI Information

  • NPI: 1043653264
  • Provider Name: TOMMIE SIMON, M.D.
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 6401 SW LEE BLVD
    LAWTON, OK
    ZIP 73505
  • Phone: (580) 699-5139

Map and Directions

Get Directions

NPI Details

Tommie Simon, M.D. is a rheumatology internal medicine in Lawton, OK with 13 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Tommie Simon, M.D. NPI is 1043653264. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

6401 SW LEE BLVD
LAWTON, OK
ZIP 73505-678
Phone: (580) 699-5139

The NPI 1043653264 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, rituximab, 10 mg (HCPCS:J9312)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • Analysis of substance using immunoassay technique, multiple step method (HCPCS:83516)
  • Uric acid level, blood (HCPCS:84550)
  • Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Rheumatoid factor level (HCPCS:86431)
  • Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Vitamin d-3 level (HCPCS:82306)
  • Acute hepatitis panel (HCPCS:80074)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Screening test for autoimmune disorder (HCPCS:86038)
  • Hepatitis b core antibody measurement (HCPCS:86704)
  • Hepatitis b surface antibody measurement (HCPCS:86706)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • Immunologic analysis for autoimmune disease, a, b, or c, single antigen (HCPCS:86812)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Measurement of dna antibody, native or double stranded (HCPCS:86225)
  • Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
  • Measurement of dna antibody, single stranded (HCPCS:86226)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
  • Total protein level, urine (HCPCS:84156)
  • Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Calcium level, total (HCPCS:82310)
  • Screening test for antineutrophil cytoplasmic antibody (HCPCS:86036)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)

The enumeration date for this NPI number is 4/8/2013 and was last updated on 11/21/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatology29814OKLAHOMAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.